Loading profile…
Pulling IRS BMF, Form 990 filings, peer benchmarks, programs, people, and grants.
Pulling IRS BMF, Form 990 filings, peer benchmarks, programs, people, and grants.
DBA: N/A
EIN 87-0790903 · Snapshot of IRS recognition, filing currency, financial health, and governance.
Directed Medical Research - Conducted medical and scientific Research and development on gene vectors and methods of gene delivery for GM2 gangliosidosis. The focus in the past year has been in preparing conducting and analyzing IND-enabling studies and vector manufacturing process development.
Principal Officer
John G Keimel
Total Revenue
$3.4M
FY2024
Total Expenses
$759K
FY2024
Net Assets
$4.5M
Program Ratio
—
expenses on programs
Employees
—
Volunteers
—
Board Members
—
Voting
—
Independent
8 answers compiled from IRS Form 990, BMF, Pub 78, and the Auto-Revocation List.